Order results by:
Issue | Title | |
Vol 9, No 1 (2017) | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease | Abstract similar documents |
G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov | ||
"... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..." | ||
Vol 13, No 6 (2021) | Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease | Abstract similar documents |
E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova | ||
"... . Patients and methods. The study included 75 patients with Parkinson's disease (PD): 49 (65.3%) women and 26 ..." | ||
Vol 12, No 5 (2020) | On the heterogeneity of depression in Parkinson’s disease | Abstract similar documents |
M. R. Nodel, N. N. Yakhno | ||
"... Depression in Parkinson’s disease (PD) is one of the leading manifestations of the disease, which ..." | ||
Vol 1, No 2 (2009) | NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE | Abstract similar documents |
M. R. Nodel', N. N. Yakhno | ||
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..." | ||
Vol 7, No 3 (2015) | Experience in using levodopa-benserazide | Abstract similar documents |
Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova | ||
"... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..." | ||
Vol 6, No 4 (2014) | The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) | Abstract similar documents |
M. R. Sapronova, N. A. Shnaider | ||
"... Parkinson’s disease (PD) is the second most common human neurodegenerative disorder. Genetically ..." | ||
Vol 9, No 3 (2017) | Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale | Abstract similar documents |
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova | ||
"... The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS ..." | ||
Vol 9, No 1 (2017) | The genetic basis of Parkinson's disease | Abstract similar documents |
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, P. I. Gurieva, N. A. Shnaider, M. M. Petrova, M. R. Sapronova | ||
"... Parkinson's disease (PD) is a multifactorial disease that develops in the presence of both genetic ..." | ||
Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
"... Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD ..." | ||
Vol 12, No 1 (2020) | Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease | Abstract similar documents |
A. A. Tappakhov, T. E. Popova, T. G. Govorova, N. A. Shnaider, M. R. Sapronova | ||
"... Levodopa remains the gold standard of treating Parkinson's disease (PD). However, the inevitable ..." | ||
Vol 14, No 1 (2022) | Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease | Abstract similar documents |
D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh | ||
"... Parkinson’s disease (PD) is a multifactorial neurodegenerative disease. Consequently, there has ..." | ||
Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
S N Illarioshkin | ||
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..." | ||
Vol 9, No 4 (2017) | Sleep disorders in Parkinson’s disease: approaches to treatment and prevention | Abstract similar documents |
M. R. Nodel, G. V. Kovrov | ||
"... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..." | ||
Vol 3, No 1 (2011) | Heart rhythm variability analysis in patients with Levy body dementia and in those with Parkinson's disease | Abstract similar documents |
I. G. Tishkova, I. S. Preobrazhenskaya | ||
"... ) and Parkinson's disease (PD). Objective: to analyze autonomic provision of cardiac performance in patients ..." | ||
Vol 5, No 2 (2013) | The clinical picture of early-stage Parkinson’s disease. errors in the diagnosis of different forms | Abstract similar documents |
E N Gubanova, Natalia Vladimirovna Fedorova | ||
"... The paper describes the clinical picture of Parkinson’s disease (PD), by indicating its stages ..." | ||
Vol 9, No 4 (2017) | Neuropsychological pattern of Parkinson's disease | Abstract similar documents |
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova, M. R. Sapronova | ||
"... The review deals with the problem of neuropsychological disorders in Parkinson's disease (PD), one ..." | ||
Vol 13, No 4 (2021) | Treatment of antipsychotic-induced parkinsonism in schizophrenic patients | Abstract similar documents |
E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
Vol 14, No 6 (2022) | A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study | Abstract similar documents |
Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova | ||
"... effects. There is anecdotal evidence that patients with Parkinson's disease (PD) treated with amantadine ..." | ||
Vol 3, No 4 (2011) | Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease | Abstract similar documents |
M. A. Bykanova, A. Yu. Kovalchuk, N. V. Pizova, N. G. Efremenko, A. A. Kostylev | ||
"... ) in 70 patients (28 men and 42 women) with Parkinson's disease (PD), by using the examination protocol ..." | ||
Vol 12, No 6 (2020) | Cerebral glucose metabolism and cognitive impairment in tremor-dominant and akinetic-rigid subtypes of Parkinson’s disease | Abstract similar documents |
I. V. Miliukhina, Yu. G. Khomenko, E. V. Gracheva, G. V. Kataeva, E. A. Gromova | ||
"... Parkinson’s disease (PD) is a disease characterized by marked phenotypic heterogeneity ..." | ||
Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
N. V. Trofimova, I. S. Preobrazhenskaya | ||
Vol 11, No 2 (2019) | Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease | Abstract similar documents |
A. G. Trufanov, A. A. Yurin, A. B. Buriak, S. A. Sandalov, M. M. Odinak, I. V. Litvinenko | ||
"... Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer ..." | ||
Vol 10, No 4 (2018) | Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease | Abstract similar documents |
M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno | ||
"... Daytime sleepiness is one of the clinically significant non-motor manifestations of Parkinson ..." | ||
Vol 13, No 3 (2021) | Profile and frequency of antiparkinsonian drugs adverse reactions: a systematic review and meta-analysis | Abstract similar documents |
A. A. Tappakhov, T. E. Popova, A. I. Vasilev, T. G. Govorova, Yu. I. Khabarova, K. A. Timofeeva, N. A. Schnaider | ||
Vol 10, No 2 (2018) | Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 | Abstract similar documents |
Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova | ||
"... Parkinson's disease (PD) is now increasingly considered as a multi-system disorder associated ..." | ||
Vol 15, No 1 (2023) | The gut microbiome as a factor in the development of Parkinson's disease | Abstract similar documents |
L. A. Brsikyan, E. A. Poluektova, M. G. Poluektov | ||
"... Parkinson's disease (PD) is a neurodegenerative disease characterized by the progressive death ..." | ||
1 - 26 of 26 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)